Pfizer Inc - Kewajiban jangka dawa perusahaan PFE

Will Pfizer Inc. (PFE) management succeed in diversifying assets and maintaining margins? The time series of the organization's long-term financial debt provides the answer, where the parameter mark equals 60.84. The holding's capital is based on global supplies of vaccines and oncology therapies. Currently, Pfizer Inc. (PFE) is overcoming rising costs and underutilized capacity by conducting a deep restructuring of its operational activities.

Long-term debt represents the aggregate of a company's obligations with a maturity exceeding twelve months. This metric measures the volume of borrowed capital, which determines financial stability and the cost of debt service. By analyzing the long-term debt of the corporation, an investor assesses asset revaluation risks. For Pfizer Inc. (PFE), such loans are critical for financing M&A transactions necessary for patent replacement and the integration of Seagen.